Evidence map›Paper›PMID 36753329›Full record

ArticleJMIR research protocols2023

Effectiveness of a Patient-Centered Assessment With a Solution-Focused Approach (DIALOG-A) in the Routine Care of Colombian Adolescents With Depression and Anxiety: Protocol for a Multicenter Cluster Randomized Controlled Trial.

Carlos Gómez-Restrepo, Jose Alejandro Rumbo Romero, Martha Rodriguez, Laura Ospina-Pinillos, Diliniya Stanislaus Sureshkumar, Stefan Priebe, Victoria Bird

Abstract read
In one paragraph

Article in JMIR research protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos Gómez-RestrepoDepartment of Clinical Epidemiology and Biostatistics, Department of Psychiatry and Mental Health, Pontificia Universidad Javeriana, Bogota, Colombia.ORCID https://orcid.org/0000-0002-9013-5384
Jose Alejandro Rumbo RomeroDepartment of Clinical Epidemiology and Biostatistics, Department of Psychiatry and Mental Health, Pontificia Universidad Javeriana, Bogota, Colombia.ORCID https://orcid.org/0000-0002-8316-5841
Martha RodriguezDepartment of Clinical Epidemiology and Biostatistics, Department of Psychiatry and Mental Health, Pontificia Universidad Javeriana, Bogota, Colombia.ORCID https://orcid.org/0000-0002-4762-5003
Laura Ospina-PinillosDepartment of Clinical Epidemiology and Biostatistics, Department of Psychiatry and Mental Health, Pontificia Universidad Javeriana, Bogota, Colombia.ORCID https://orcid.org/0000-0002-7929-1511
Diliniya Stanislaus SureshkumarUnit for Social and Community Psychiatry, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.ORCID https://orcid.org/0000-0002-2384-3321
Stefan PriebeUnit for Social and Community Psychiatry, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.ORCID https://orcid.org/0000-0001-9864-3394
Victoria Bird *Unit for Social and Community Psychiatry, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.ORCID https://orcid.org/0000-0002-2053-7679

Funding

Medical Research Council MR/S023674/1
6 · The paper itself

Abstract

backgroundColombia is a middle-income country in South America, which has historically had high rates of mental health problems, coupled with a scarcity of mental health care. There is growing concern for the mental health of the adolescent population within this region. There is a significant treatment gap for young people, especially those living in the most vulnerable areas. DIALOG+ is a low-cost patient-centered intervention that can potentially improve the delivery of care and quality of life for adolescents with mental health problems.

objectiveThis exploratory randomized controlled trial aims to evaluate the effectiveness, acceptability, and feasibility of an adapted version of the DIALOG+ intervention (DIALOG-A) in the community treatment of Colombian adolescents with depression and anxiety.

methodsIn total, 18 clinicians and 108 adolescents will be recruited from primary health care services in Bogota and Duitama, Colombia. Clinicians will be randomized 2:1 to either the intervention (12 clinicians:72 adolescents) or control group (6 clinicians:36 adolescents). In the intervention arm, clinicians will use DIALOG-A with adolescents once per month over 6 months. The control arm will continue to receive routine care. Outcomes will be measured at baseline, 6 months, and 9 months following randomization. Semistructured interviews with all clinicians and a subset of adolescents in the intervention arm will be conducted at the end of the intervention period. Quantitative and qualitative analysis of the data will be conducted.

resultsTrial recruitment was completed toward the end of October 2022, and follow-up is anticipated to last through to October 2023.

conclusionsThis is the first study to test an adapted resource-orientated intervention (DIALOG-A) in the treatment of adolescents with depression and anxiety attending primary care services. If the results are positive, DIALOG-A can be implemented in the routine care of adolescents with these mental health problems and provide valuable insight to other middle-income countries.

trial registrationISRCTN Registry ISRCTN13980767; https://www.isrctn.com/ISRCTN13980767?q=ISRCTN13980767. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/43401.

Indexed as

adolescentanxietyColombiadepressionmental healthprimary health carerandomised controlled trialtelemedicine

Identifiers

PMID36753329
PMCPMC9947748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.